204 related articles for article (PubMed ID: 29404807)
41. Adolescent physical activity in relation to breast cancer risk.
Boeke CE; Eliassen AH; Oh H; Spiegelman D; Willett WC; Tamimi RM
Breast Cancer Res Treat; 2014 Jun; 145(3):715-24. PubMed ID: 24682675
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
[TBL] [Abstract][Full Text] [Related]
43. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
Andrieu N; Easton DF; Chang-Claude J; Rookus MA; Brohet R; Cardis E; Antoniou AC; Wagner T; Simard J; Evans G; Peock S; Fricker JP; Nogues C; Van't Veer L; Van Leeuwen FE; Goldgar DE
J Clin Oncol; 2006 Jul; 24(21):3361-6. PubMed ID: 16801631
[TBL] [Abstract][Full Text] [Related]
44. Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age.
Tea MK; Weghofer A; Wagner K; Singer CF
Maturitas; 2013 Jun; 75(2):148-51. PubMed ID: 23528734
[TBL] [Abstract][Full Text] [Related]
45. Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
Manders P; Pijpe A; Hooning MJ; Kluijt I; Vasen HF; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer H; Ausems MG; van Os TA; Gomez-Garcia EB; Brohet RM; ; van Leeuwen FE; Rookus MA
Breast Cancer Res Treat; 2011 Feb; 126(1):193-202. PubMed ID: 20730487
[TBL] [Abstract][Full Text] [Related]
46. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.
Cibula D; Zikan M; Dusek L; Majek O
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1197-207. PubMed ID: 21916573
[TBL] [Abstract][Full Text] [Related]
47. Mammographic density and breast cancer in women from high risk families.
Ramón Y Cajal T; Chirivella I; Miranda J; Teule A; Izquierdo Á; Balmaña J; Sánchez-Heras AB; Llort G; Fisas D; Lope V; Hernández-Agudo E; Juan-Fita MJ; Tena I; Robles L; Guillén-Ponce C; Pérez-Segura P; Luque-Molina MS; Hernando-Polo S; Salinas M; Brunet J; Salas-Trejo MD; Barnadas A; Pollán M
Breast Cancer Res; 2015 Jul; 17(1):93. PubMed ID: 26163143
[TBL] [Abstract][Full Text] [Related]
48. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Shah PD; Patil S; Dickler MN; Offit K; Hudis CA; Robson ME
Cancer; 2016 Apr; 122(8):1178-84. PubMed ID: 26859126
[TBL] [Abstract][Full Text] [Related]
49. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
[TBL] [Abstract][Full Text] [Related]
50. The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Vencken PM; Kriege M; Hooning M; Menke-Pluymers MB; Heemskerk-Gerritsen BA; van Doorn LC; Collée MM; Jager A; van Montfort C; Burger CW; Seynaeve C
Cancer; 2013 Mar; 119(5):955-62. PubMed ID: 23165859
[TBL] [Abstract][Full Text] [Related]
51. A prospective study of age-specific physical activity and premenopausal breast cancer.
Maruti SS; Willett WC; Feskanich D; Rosner B; Colditz GA
J Natl Cancer Inst; 2008 May; 100(10):728-37. PubMed ID: 18477801
[TBL] [Abstract][Full Text] [Related]
52. Moderate-to-vigorous intensity physical activity across the life course and risk of pre- and post-menopausal breast cancer.
Kobayashi LC; Janssen I; Richardson H; Lai AS; Spinelli JJ; Aronson KJ
Breast Cancer Res Treat; 2013 Jun; 139(3):851-61. PubMed ID: 23771716
[TBL] [Abstract][Full Text] [Related]
53. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
[TBL] [Abstract][Full Text] [Related]
54. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
Calderon-Margalit R; Paltiel O
Int J Cancer; 2004 Nov; 112(3):357-64. PubMed ID: 15382059
[TBL] [Abstract][Full Text] [Related]
55. Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women.
Si S; Boyle T; Heyworth J; Glass DC; Saunders C; Fritschi L
Breast Cancer Res Treat; 2015 Jul; 152(2):449-62. PubMed ID: 26126973
[TBL] [Abstract][Full Text] [Related]
56. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
[TBL] [Abstract][Full Text] [Related]
57. Fat intake and its relationship with pre- and post-menopausal breast cancer risk: a case-control study in Malaysia.
Sulaiman S; Shahril MR; Shaharudin SH; Emran NA; Muhammad R; Ismail F; Husain SN
Asian Pac J Cancer Prev; 2011; 12(9):2167-78. PubMed ID: 22296351
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
Hughes DJ; Ginolhac SM; Coupier I; Barjhoux L; Gaborieau V; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Sobol H; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Yannoukakos D; Mazoyer S; Lynch HT; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
Int J Cancer; 2005 Nov; 117(2):230-3. PubMed ID: 15900600
[TBL] [Abstract][Full Text] [Related]
59. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
60. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study.
Jones T; McCarthy AM; Kim Y; Armstrong K
Cancer Med; 2017 Jul; 6(7):1787-1798. PubMed ID: 28627138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]